New drug ASKB589 tested against advanced cancers
NCT ID NCT04632108
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 29 times
Summary
This study tests a new drug called ASKB589 in people with advanced or metastatic solid tumors, especially stomach and pancreatic cancers. The goal is to check safety, side effects, and how well the drug works. About 199 participants will receive the drug to find the best dose and see if it can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing cancer hospital
Beijing, Beijing Municipality, 100089, China
-
Linyi cancer hospital
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.